Article
Identification of a 16-MTGs Prognostic Signature in Diffuse large B-cell lymphoma
2023-04-28
Abstract excerpt
<title>Abstract</title> <p> <bold>Background:</bold> Diffuse large B-cell lymphoma (DLBCL) is one of the largest lymphoma subcategories. Usually, 50-70% of DLBCL patients can be cured by the standard treatment. But at least one third have bad prognosis. Based on this situation, the research on DLBCL therapy strategies is still indispensable. <bold>Method:</bold> A prognostic signature was built according to p...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- b7cdb185-e449-5e07-854a-822ebdf18399
- DOI
- 10.21203/rs.3.rs-1468741/v2
